Making the discoveries that defeat cancer

  • Home »
  • Research »
  • Repository

  • Administrators Login

  • Repository Homepage
  • About the Repository
  • Browse the Repository
  • Search the Repository
  • Contribute an Article
  • Missing Publications
  • Repository Help

A microRNA DNA methylation signature for human cancer metastasis

Tools
- Tools
+ Tools

Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sanchez-Cespedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., Gallagher, W. M., Eccles, S. A., Croce, C. M., Esteller, M. (2008) A microRNA DNA methylation signature for human cancer metastasis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 105 (36). pp. 13556-13561. ISSN 0027-8424

Full text not available from this repository.

A copy of the full text may be available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC252887...

Abstract

MicroRNAs (miRNAs) are small, noncoding RNAs that can contribute to cancer development and progression by acting as oncogenes or tumor suppressor genes. Recent studies have also linked different sets of miRNAs to metastasis through either the promotion or suppression of this malignant process. Interestingly, epigenetic silencing of miRNAs with tumor suppressor features by CpG island hypermethylation is also emerging as a common hallmark of human tumors. Thus, we wondered whether there was a miRNA hypermethylation profile characteristic of human metastasis. We used a pharmacological and genomic approach to reveal this aberrant epigenetic silencing program by treating lymph node metastatic cancer cells with a DNA demethylating agent followed by hybridization to an expression microarray. Among the miRNAs that were reactivated upon drug treatment, miR-148a, miR-34b/c, and miR-9 were found to undergo specific hypermethylation-associated silencing in cancer cells compared with normal tissues. The reintroduction of miR-148a and miR-34b/c in cancer cells with epigenetic inactivation inhibited their motility, reduced tumor growth, and inhibited metastasis formation in xenograft models' with an associated down-regulation of the miRNA oncogenic target genes, such as C-MYC, E2F3, CDK6, and TGIF2. Most important, the involvement of miR-148a, miR-34b/c, and miR-9 hypermethylation in metastasis formation was also suggested in human primary malignancies (n = 207) because it was significantly associated with the appearance of lymph node metastasis. Our findings indicate that DNA methylation-associated silencing of tumor suppressor miRNAs contributes to the development of human cancer metastasis.

Item Type: Article
Authors (ICR Faculty only): Eccles, Sue
All Authors: Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sanchez-Cespedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., Gallagher, W. M., Eccles, S. A., Croce, C. M., Esteller, M.
Uncontrolled Keywords: TUMOR-SUPPRESSOR MICRORNAS; BREAST-CANCER; P53; EXPRESSION; CELLS; GENE; HYPERMETHYLATION; TRANSCRIPTS; ACTIVATION; CARCINOMA
Research teams: ICR divisions > Cancer Therapeutics > Tumour Biology & Metastasis
Depositing User: Users 10 not found.
Date Deposited: 07 Oct 2008 13:09
Last Modified: 10 Feb 2010 11:50
URI: http://publications.icr.ac.uk/id/eprint/6996

Actions (login required)

View Item View Item
The Royal Marsden - NHS foundation trust